Trademark Search in Canada

Nexfill

View On IC.GC.CA

ADVERTISED

on 24 Jan 2025

Last Applicant/ Owned by

Nexus Pharma Co.,Ltd.

6F 71, Gonghang-daero 45-gil, Gangseo-guSeoul

Serial Number

2092829 filed on 28^th Jan 2021

Registration Number

TMA1285853 registered on 24^th Jan 2025

Registration expiry Date

28^th Jan 2031

Correspondent Address

CPST INTELLECTUAL PROPERTY INC.

130 Queens Quay EastEast Tower, Suite 809Toronto,

ONTARIO

M5A0P6

Nexfill

Trademark usage description

implantable medicines being surgical implants comprised of living tissues; muscle relaxants; anti-aging medicated skin preparations; transdermal patch Read More

Classification Information

Class [005]
Implantable medicines being surgical implants comprised of living tissues; muscle relaxants; anti-aging medicated skin preparations; Transdermal patches for medical treatment of wrinkles, dermatitis, skin pigmentation diseases, for acne scars, facial flushing, and skin moles and for skin care after dermabrasion; Pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; antimicrobials for dermatologic use; biological biomaterials for tissue restoration, namely, natural biomaterials for augmentation of bone and tissue for medical purposes.

Classification kind code

Mark Details

Serial Number

2092829

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 1^st Dec 2022	Agent Changed
Submitted for opposition 22 on 26^th Jul 2022	Search Recorded
Submitted for opposition 20 on 26^th Jul 2022	Examiner's First Report
Submitted for opposition 223 on 26^th Jul 2022	Total Provisional Refusal
Submitted for opposition 256 on 18^th Jan 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 18^th Mar 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 17^th Mar 2021	Formalized
Submitted for opposition 1 on 17^th Mar 2021	Created
Submitted for opposition 228 on 28^th Jan 2021	International Registration
Submitted for opposition 30 on 28^th Jan 2021	Filed